Investor Whitmore Bradford T
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Whitmore Bradford T . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-06-02 13D/A SLSN / Solesence, Inc. 49,826,805 49,826,805
2025-03-04 13G/A CLSD / Clearside Biomedical, Inc. 6,264,964 6,523,511
2024-09-03 13D/A ULBI / Ultralife Corporation 5,538,073 6,197,741
2024-09-03 13D/A SLSN / Solesence, Inc. 49,826,805 49,826,805
2024-06-26 13D/A SLSN / Solesence, Inc. 49,826,805 49,826,805
2024-03-05 13D/A SLSN / Solesence, Inc. 34,826,805 49,826,805
2024-02-12 13D/A SLSN / Solesence, Inc. 31,008,278 34,826,805
2023-11-16 13D/A SLSN / Solesence, Inc. 30,278,154 31,008,278
2023-11-01 13G/A CLSD / Clearside Biomedical, Inc. 6,017,852 6,264,964
2023-01-04 13G/A CLSD / Clearside Biomedical, Inc. 5,878,197 6,017,852
2022-01-24 13G/A CLSD / Clearside Biomedical, Inc. 6,365,186 5,878,197
2021-12-23 13D/A NANX / Solesence, Inc. 30,182,599 30,278,154
2021-01-07 13G/A CLSD / Clearside Biomedical, Inc. 5,435,341 6,365,186
2020-11-06 13D/A ULBI / Ultralife Corporation 5,142,726 5,538,073
2020-11-06 13D/A NANX / Solesence, Inc. 30,182,599 30,182,599
2020-10-01 13D/A NANX / Solesence, Inc. 30,182,599 30,182,599
2019-11-26 13G/A CLSD / Clearside Biomedical, Inc. 3,200,000 5,435,341
2019-11-15 13D/A NANX / Solesence, Inc. 20,182,599 30,182,599
2019-05-15 13D/A NANX / Solesence, Inc. 15,993,599 20,182,599
2019-01-03 13G CLSD / Clearside Biomedical, Inc. 3,200,000
2017-12-21 13D/A NANX / Solesence, Inc. 13,283,739 15,993,599
2016-02-10 13D/A NANX / Solesence, Inc. 13,283,739
2012-12-17 13D/A ULBI / Ultralife Corporation 5,142,726
2012-09-14 13D/A NANX / Solesence, Inc. 10,938,939
2012-08-02 13D/A NANX / Solesence, Inc. 10,938,939
2012-03-16 13D/A NANX / Solesence, Inc. 5,228,947